As the complexity of clinical trials continues to increase the importance of contract research organizations (CROs) to the pharmaceutical industry has increased significantly. Outsourcing allows pharmaceutical companies to utilize on-demand services, improving operational efficiencies by accessing therapeutic expertise and geographic reach. This reflects a sharper focus on core competencies and a shift to allow CROs to manage and conduct clinical trials.
The relationship between sponsors and CROs is strengthening as outsourcing becomes a clinical trial mainstay. Yet, outsourcing of clinical trials introduces additional complexities around quality, oversight, collaboration, and governance. Communication and transparency are required to move the clinical trial forward efficiently, but how can you do this when you’re working with multiple CROs all using inconsistent reporting conventions?
Simply handing off multi-million-dollar studies to CROs without carefully crafted plans for communications and reporting operational data as the study unfolds is hardly a wise move, yet what kind of oversight is needed?
Key Learning Objectives:
In this webcast we will explore:
Who Should Attend:
This webcast is applicable to:
For questions please contact Martha Devia: firstname.lastname@example.org
As part of our commitment to providing education to healthcare and industry sciences professionals during the COVID-19 pandemic, attendance at this webinar is free of charge. However, if you’d like to make a donation to help first responders through the New Jersey Pandemic Relief Fund, MJH Life Sciences™, our parent company, will match all contributions. To make a donation, please click “donate” below and complete the requested information.